| LIPID_ID | FA0091 |
| CHEM_NA | (METHYL)-13-HYDROPEROXY-9,11,15-OCTADECAT |
| RIENOIC ACID(OCTADECATRIENOATE) |
| COMMON_NA |
| MOL_FORMULA | C18H30O4 |
| MOL_WT | 310 |
| ABBREVIATION | 18:3(ω4,6,9)(13-OOH) |
| MELT_PT |
| BOIL_PT |
| OPT_ROT |
| REFRA_IND |
| DENSITY |
| SOLUBILITY |
| UV_SPEC | (ME-ESTER;AFTER REDUCTION;IN ETOH)(097), |
| CIS,TRANS,CIS ISOMER: λmax=233nm |
| TRANS,TRANS,CIS ISOMER: λmax=232nm |
| IR_SPEC | (ME-ESTER;AFTER REDUCTION)(097/098), |
| CIS,TRANS,CIS ISOMER:989-983 AND 950-945cm-1; |
| TRANS,TRANS,CIS ISOMER:992-983cm-1 |
| (ME-ESTER)(099),OOH GROUP:3400cm-1 |
| NMR_SPEC | 1H-NMR(CIS,TRANS,CIS-ISOMER)(036):C10:5.95ppm; |
| C11:6.54ppm;C12:5.54ppm; |
| C13:4.38ppm;J10-11=11Hz;J11-12=15Hz[C11-12:TR |
| ANS];J12-13=8Hz |
| 1H-NMR(CIS,TRANS,CIS-ISOMER;AFTER |
| REDUCTION)(036):C10:5.94ppm;C11:6.49ppm; |
| C12:5.64ppm;C13:4.20ppm;J10-1 |
| MS_SPEC | EI-MS(ME-ESTER;AFTER REDUCTION AND |
| HYDROGENATION)(009/097):M/E=243[O=CH(CH2)11 |
| C(=OH)OCH3];214[CH2(CH2)10C(=OH)OCH3];211[O= |
| CH(CH2)11C=O],GC-EI-MS(ME-ESTER;AFTER |
| REDUCTION AND |
| TMS)(010/098):M/E=380[M];365[M-CH3];311[SMTO |
| =CH-CH=CH-CH=CH-(CH2)7-COOCH3],GC-EI |
| NOTE_SPEC |
| SOURCE | ﾘﾉﾚﾝの自動酸化(001/011/012/016ｰ020/043/044) |
| ﾘﾉﾚﾝの一重項酸素酸化(011/012/017ｰ020/043) |
| ﾘﾉﾚﾝ酸と大豆ﾘﾎﾟｷｼｹﾞﾅｰｾﾞとの反応(pH:8.7,25ﾟC)により |
| 生成（二重結合は，CIS, TRANS,CIS)(036) |
| ﾘﾉﾚﾝ酸とｱﾏﾆﾘﾎﾟｷｼｹﾞﾅｰｾﾞとの反応(pH:6.5,24ﾟC)により |
| 生成(041)． |
| BIOL_ACTIV | 体内に取込まれたり，体内で生成したﾋﾄﾞﾛﾍﾟﾙｵｷｼﾄﾞは |
| ，様々な生体障害を引起こす(062-068)．鉄ｲｵﾝとｱｽｺﾙ |
| ﾋﾞﾝ酸の存在下でDNAと反応し，強い蛍光を生ずる(111) |
| ． |
| NOTE |
| 1998年8月24日 | 91 / 513 ページ |